Agios Pharmaceuticals price target raised to $50 from $46
Benzinga reports B of A Securities raised its Agios Pharmaceuticals price target to $50.00 per share from $46.00.
Benzinga reports B of A Securities raised its Agios Pharmaceuticals price target to $50.00 per share from $46.00.